MedPath

Evaluation of insulin resistance in obese children and adolescents referred to a paediatric obesity outpatient clinic: a follow up study.

Completed
Conditions
Obesitas
insulin resistance
10018424
Registration Number
NL-OMON39352
Lead Sponsor
Sint Antonius Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
89
Inclusion Criteria

Signed informed consent.
The need for informed consent is waived in case parents/caregivers and subjects during the visit to the outpatient clinic did not make an objection orally against the use of their clinical data. In the
latter case, routinely collected clinical and laboratory data will be used only.

Exclusion Criteria

Oral objection of subject and/or parents/caregivers for use of clinical data.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameters/endpoints:<br /><br>Primary endpoint is the HOMA-IR measured between 2-5 years after diagnosis of<br /><br>insulin resistance.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints are BMI, FPG, T2DM and quality of life between 2-5 years<br /><br>after diagnosis of insulin resistance</p><br>
© Copyright 2025. All Rights Reserved by MedPath